Results

Total Results: 1,265 records

Showing results for "participants".

321. Archived: Suicide Risk in Adolescents, Adults and Older Adults: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/suicide-risk-in-adolescents-adults-and-older-adults-screening
     May 20, 2014 - Study populations primarily consisted of participants at high risk for suicide, most with recent suicide … In addition, differential ascertainment may have biased the results; a higher proportion of participants … “Vigor” was the only characteristic that was reported to be higher in screened participants. … In a study of a video-based problem-solving intervention, none of the participants withdrew because of … In the medication trial that evaluated treatment with lithium, a higher percentage of participants in

322. Evidence Summary: Obesity in Children and Adolescents: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/obesity-in-children-and-adolescents-screening
     June 20, 2017 - Participants in metformin trials had a higher BMI than those in behavior-based interventions, with a … Gastrointestinal adverse effects were common but not serious in participants taking metformin. … For example, abdominal pain or cramps were reported by 16% to 65% of participants taking orlistat and … In 2 trials, fecal incontinence was reported in 9% to 10% of participants taking orlistat and 0% to 1% … discontinuations due to adverse effects were relatively rare (<5%) but about twice as common among participants

323. Archived: Evidence Summary: Obesity in Children and Adolescents: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/obesity-in-children-and-adolescents-screening-june-2017
     June 20, 2017 - Participants in metformin trials had a higher BMI than those in behavior-based interventions, with a … Gastrointestinal adverse effects were common but not serious in participants taking metformin. … For example, abdominal pain or cramps were reported by 16% to 65% of participants taking orlistat and … In 2 trials, fecal incontinence was reported in 9% to 10% of participants taking orlistat and 0% to 1% … discontinuations due to adverse effects were relatively rare (<5%) but about twice as common among participants

324. Serological Screening for Genital Herpes: A Reaffirmation Evidence Update for the USPSTF (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/ghTxWfpzXrJRXU8SZECvsk
     August 01, 2022 - Participants have mild Alzheimer’s disease and must test positive for HSV-1 or HSV-2 antibodies. … In one study (N=2,393 participants), 98 participants (4.1%) (from either study arm) experienced asymptomatic … Adult men and women study participants from the University of Washington Virology Research Clinic† … † Participants were enrolled in prospective studies of the natural history of genital HSV infection … Did the whole or a random selection of the participants receive the Western blot?

325. Serological Screening for Genital Herpes: A Reaffirmation Evidence Update for the U.S. Preventive Services Task Force (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/XW6XUe2wRmkM-6Rrbn_462
     February 01, 2023 - Participants have mild Alzheimer’s disease and must test positive for HSV-1 or HSV-2 antibodies. … In one study (N=2,393 participants), 98 participants (4.1%) (from either study arm) experienced asymptomatic … Adult men and women study participants from the University of Washington Virology Research Clinic† … † Participants were enrolled in prospective studies of the natural history of genital HSV infection … Did the whole or a random selection of the participants receive the Western blot?

326. Recommendation: Unhealthy Drug Use: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/drug-use-illicit-screening
     June 09, 2020 - Trials recruited participants from inpatient settings, drug treatment programs, and criminal justice … Most participants were adult males younger than 30 years. … Sample sizes ranged from 31 to 306 (total N = 1718 participants). … The severity of drug use in trial participants varied greatly. … Thirty-eight percent to 98% of participants completed assessments at designated follow-up points.

327. Archived: Routine Vitamin Supplementation to Prevent Cancer: Update of the Evidence from Randomized Controlled Trials 1999-2002*: Vitamin Supplementation to Prevent Cancer and CVD: Counseling and Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/routine-vitamin-supplementation-to-prevent-cancer-update-of-the-evidence-from-randomized-controlled-trials-19992002/vitamin-supplementation-to-prevent-cancer-and-cvd-counseling-and-preventive-medication-2003
     June 15, 2003 - The participants were followed for an average of 5 years and assessed for incidence of major coronary … Malila and colleagues 11 analyzed data from a cohort of 26,951 participants of the ATBC trial who had … Among the 29,102 participants of the ATBC trial who had had serum alpha-tocopherol levels taken prior … Colorectal cancer incidence. 26,951 participants of ATBC study with all baseline data including baseline … Lung cancer incidence and mortality. 29,102 participants of ATBC study with baseline serum alpha-tocopherol

328. Evidence Summary: Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/statin-use-in-adults-preventive-medication
     August 23, 2022 - adults 40 years or older without prior CVD events; studies of populations in which less than 10% of participants … mixed primary and secondary prevention data (n = 6595) from WOSCOPS 33 (<10% secondary prevention participants … restricted to good-quality trials, primary prevention trials (trials with <10% secondary prevention participants … Baseline characteristics of participants in the JUPITER trial, a randomized placebo-controlled primary … with CVD risk factors Trials primarily enrolled White participants; mean age was 52 to 66 y in all

329. Screening for HIV: Systematic Review to Update the 2005 USPSTF Recommendation (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/dvcAbDQWejyK38oxF8qgka
     November 01, 2012 - com- bined data from 12 to 23 U.S., European, and Australian cohorts (ranging from 9000 to �60 000 participants … Another randomized trial (39) with 816 participants found that ART initiation at CD4 counts less than … , the NA-ACCORD (North American AIDS Cohort Collaboration on Research and Design) (44), with 17 517 participants … Major clinical outcomes in antiretroviral therapy (ART)-naive participants and in those not receiving … CD4 Cell Counts at HIV Diagnosis among HIV Outpatient Study Participants, 2000-2009.

330. Screening for Unhealthy Drug Use: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/R3y9LSud52CGL8mG4wvxoT
     June 09, 2020 - Twenty-eight studies17-44 (reported in 37 publications17-52) with 65 720 participants addressed the accuracy … postpartum persons (5 studies) No. analyzed Range No. analyzed Range No. analyzed Range Studiesa Participants … Sensitivity Specificity Studiesa Participants Sensitivity Specificity Studiesa Participants Sensitivity … Study participants were predominantly men (proportion of women ranged from 25%-43%), and mean age ranged … Clinical profile of participants in a brief intervention program for cannabis use disorder.

331. Evidence Summary: Bleeding Risks With Aspirin Use: Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-bleeding-risks-with-aspirin-use/aspirin-to-prevent-cardiovascular-disease-and-cancer
     April 11, 2016 - Cohort) Mean major bleeding rates among control group participants from 6 CVD primary prevention trials … In contrast, hospitalization rates for GI bleeding among control participants in the cohort study 22 … However, many trials restricted enrollment to participants without clear bleeding risk factors. … Control group trial participants had much lower average risks for bleeding than those from cohort studies … This probably reflects the fact that, beyond the variability in risk represented by age and sex, participants

332. Evidence Summary: Screening for Familial Hypercholesterolemia: Lipid Disorders in Children and Adolescents: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-screening-for-familial-hypercholesterolemia/lipid-disorders-in-children-screening
     August 09, 2016 - Study Selection: Fair- and good-quality studies in English with participants 0 to 20 years of age. … Studies with mixed dyslipidemic populations were included when the outcome data for participants with … Studies in which the researchers specifically identified participants with FH using any specified and … None of the studies reported treating screening-detected participants. … Participants were recruited from tertiary clinics and were not screen-identified.

333. Archived: Evidence Summary: Bleeding Risks With Aspirin Use: Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-bleeding-risks-with-aspirin-use/aspirin-to-prevent-cardiovascular-disease-and-cancer-april-2016
     April 11, 2016 - Cohort) Mean major bleeding rates among control group participants from 6 CVD primary prevention trials … In contrast, hospitalization rates for GI bleeding among control participants in the cohort study 22 … However, many trials restricted enrollment to participants without clear bleeding risk factors. … Control group trial participants had much lower average risks for bleeding than those from cohort studies … This probably reflects the fact that, beyond the variability in risk represented by age and sex, participants

334. Archived: Evidence Summary: Screening for Familial Hypercholesterolemia: Lipid Disorders in Children and Adolescents: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-screening-for-familial-hypercholesterolemia/lipid-disorders-in-children-screening-july-2016
     August 09, 2016 - Study Selection: Fair- and good-quality studies in English with participants 0 to 20 years of age. … Studies with mixed dyslipidemic populations were included when the outcome data for participants with … Studies in which the researchers specifically identified participants with FH using any specified and … None of the studies reported treating screening-detected participants. … Participants were recruited from tertiary clinics and were not screen-identified.

335. Primary Care Screening for Abdominal Aortic Aneurysm: Updated Evidence Report and Systematic Review for the USPSTF (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/XAaYbGVD_xRoMfQ-huJkJq
     December 10, 2019 - Brown LC, Powell JT; UK Small Aneurysm Trial Participants. … Brown LC, Thompson SG, Greenhalgh RM, Powell JT; UK Small Aneurysm Trial Participants. … Forbes JF, Brady AR, Brown LC, Fowkes FG; UK Small Aneurysm Trial Participants. … Small Aneurysm Trial Participants. … Powell JT, Brady AR, Brown LC, Forbes JF; UK Small Aneurysm Trial Participants.

336. Reducing Risk for Mother-to-Infant Transmission of Hepatitis C Virus: A Systematic Review for the USPSTF (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/5V8t2G6kCTJU6fLBHnfTuR
     January 01, 2013 - Mother-to-Child Transmission of HCV* Variable Overall Strength of Evidence Studies Identified, n Participants … Breastfeeding Practices and Mother-to-Infant Transmission of HCV Study, Year; Country (Reference) Quality Participants … , n Age, y Nonwhite Participants, % HIV-Positive Participants, % HCV Viral Load, RNA copies �106/ … 158 • Number 2 www.annals.org Appendix Table—Continued Study, Year; Country (Reference) Quality Participants … , n Age, y Nonwhite Participants, % HIV-Positive Participants, % HCV Viral Load, RNA copies �106/

337. Draft Research Plan: Screening for Atrial Fibrillation | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/draft-research-plan/screening-atrial-fibrillation
     March 26, 2020 - To approximate screen-detected persons with AF, we will aim to stratify analyses based on whether participants … clearly enroll screen-detected or asymptomatic populations, we will not exclude studies based on whether participants

338. Draft Research Plan: Atrial Fibrillation: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/draft-research-plan/atrial-fibrillation-with-ecg
     March 26, 2020 - To approximate screen-detected persons with AF, we will aim to stratify analyses based on whether participants … clearly enroll screen-detected or asymptomatic populations, we will not exclude studies based on whether participants

339. Draft Research Plan: Screening for Depression, Anxiety, and Suicide Risk in Children and Adolescents | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/draft-research-plan/screening-depression-anxiety-suicide-risk-children-adolescents
     April 30, 2020 - comparable to primary care setting) General emergency departments KQs 4, 5: 50% or more of the study participants … comparative cohort and case-control observational studies Harms of pharmacotherapy only: large (>1,000 participants

340. Draft Research Plan: Anxiety in Children and Adolescents: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/draft-research-plan/screening-anxiety-children-adolescents
     March 29, 2022 - comparable to primary care setting) General emergency departments KQs 4, 5:  50% or more of the study participants … comparative cohort and case-control observational studies Harms of pharmacotherapy only:  large (>1,000 participants